These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8525228)

  • 1. [Pharmacokinetics and clearance of ciprofloxacin and amikacin in continuous hemodialysis].
    Cotera A; Aguila R; Gaete L; Saffie A; Lorca E; Thambo S
    Rev Med Chil; 1995 Jun; 123(6):742-8. PubMed ID: 8525228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of ciprofloxacin and vancomycin in patients with acute renal failure treated by continuous haemodialysis.
    Davies SP; Azadian BS; Kox WJ; Brown EA
    Nephrol Dial Transplant; 1992; 7(8):848-54. PubMed ID: 1325620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ciprofloxacin in subjects with varying degrees of renal function and undergoing hemodialysis or CAPD.
    Kowalsky SF; Echols M; Schwartz MT; Bailie GR; McCormick E
    Clin Nephrol; 1993 Jan; 39(1):53-8. PubMed ID: 8428409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of antimicrobial agents in anuric patients during continuous venovenous haemofiltration.
    Joos B; Schmidli M; Keusch G
    Nephrol Dial Transplant; 1996 Aug; 11(8):1582-5. PubMed ID: 8856215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance of linezolid via continuous venovenous hemodiafiltration.
    Mauro LS; Peloquin CA; Schmude K; Assaly R; Malhotra D
    Am J Kidney Dis; 2006 Jun; 47(6):e83-6. PubMed ID: 16731287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapy.
    Taccone FS; de Backer D; Laterre PF; Spapen H; Dugernier T; Delattre I; Wallemacq P; Vincent JL; Jacobs F
    Int J Antimicrob Agents; 2011 Jun; 37(6):531-5. PubMed ID: 21489756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of ciprofloxacin in ICU patients on continuous veno-venous haemodiafiltration.
    Wallis SC; Mullany DV; Lipman J; Rickard CM; Daley PJ
    Intensive Care Med; 2001 Apr; 27(4):665-72. PubMed ID: 11398692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The administration of ciprofloxacin during continuous renal replacement therapy: pilot study.
    Hayakawa M; Fujita I; Iseki K; Gando S
    ASAIO J; 2009; 55(3):243-5. PubMed ID: 19318919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration.
    DelDot ME; Lipman J; Tett SE
    Br J Clin Pharmacol; 2004 Sep; 58(3):259-68. PubMed ID: 15327585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and the most suitable regimen of panipenem/beta mipron in critically ill patients receiving continuous renal replacement therapy: a pilot study.
    Hayakawa M; Ito Y; Fujita I; Iseki K; Gando S
    ASAIO J; 2006; 52(4):398-403. PubMed ID: 16883119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition kinetics of ciprofloxacin in lactating goats.
    el-Banna HA; Abo el-Sooud K
    Dtsch Tierarztl Wochenschr; 1998 Jan; 105(1):35-8. PubMed ID: 9499632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable disposition of ciprofloxacin in critically ill patients undergoing continuous arteriovenous hemodiafiltration.
    Fish DN; Bainbridge JL; Peloquin CA
    Pharmacotherapy; 1995; 15(2):236-45. PubMed ID: 7624271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs.
    Anadón A; Martínez-Larrañaga MR; Díaz MJ; Fernández-Cruz ML; Martínez MA; Frejo MT; Martínez M; Iturbe J; Tafur M
    Am J Vet Res; 1999 Nov; 60(11):1377-82. PubMed ID: 10566812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciprofloxacin and oxociprofloxacin pharmacokinetics in patients on haemodialysis.
    Drinovec J; Mrhar A; Bren A; Primozic S; Karba R; Varl J; Kozjek F
    J Chemother; 1989 Jul; 1(4 Suppl):565-6. PubMed ID: 16312534
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative bioequivalence and pharmacokinetics of ciprofloxacin in healthy male subjects.
    Khan MK; Khan MF
    Pak J Pharm Sci; 2009 Jan; 22(1):1-7. PubMed ID: 19168412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
    Yang RH; Rong XZ; Hua R; Zhang T
    Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of moxifloxacin in patients undergoing continuous venovenous haemodiafiltration.
    Fuhrmann V; Schenk P; Jaeger W; Ahmed S; Thalhammer F
    J Antimicrob Chemother; 2004 Oct; 54(4):780-4. PubMed ID: 15347636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
    Zehnder C; Gutzwiller JP; Renggli K
    Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis.
    Montgomery MJ; Beringer PM; Aminimanizani A; Louie SG; Shapiro BJ; Jelliffe R; Gill MA
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3468-73. PubMed ID: 11709326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodialysis clearance of ethosuximide in patients with chronic renal disease.
    Marbury TC; Lee CS; Perchalski RJ; Wilder BJ
    Am J Hosp Pharm; 1981 Nov; 38(11):1757-60. PubMed ID: 7304633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.